Synonym: 1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one
CAS Number: 37762-06-4
Empirical Formula (Hill Notation): C13H13N5O2
Molecular Weight: 271.27
EC Number: 253-655-1
MDL Number: MFCD00214073
Linear Formula: C13H13N5O2
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: Z0878-100MG
color |
white |
form |
solid |
InChI |
1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19) |
InChI key |
REZGGXNDEMKIQB-UHFFFAOYSA-N |
Quality Level |
200 ![External link](https://krackeler.com/images/sigma/ext-link.gif) |
SMILES string |
CCCOc1ccccc1C2=NC(=O)c3nn[nH]c3N2 |
solubility |
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.11 mg/mL |
|
DMSO: 10 mg/mL |
|
H2O: insoluble |
Application: |
Zaprinast has been used to determine its inhibitory effect on the meiosis of oocytes by germinal vesicle breakdown (GVBD) assay and to test the inhibitory effect of it on the retinal cells by immunohistochemistry. |
Biochem/physiol Actions: |
Selective inhibitor of cGMP-specific phosphodiesterases V and VI (PDE5/6) and an agonist at the G protein-coupled receptor 35 (GPR35). |
Biochem/physiol Actions: |
Zaprinast insubstantially inhibits phosphodiesterase 10 and 11 (PDE10 and PDE11). It also exhibits vasodilating effects. |
Packaging: |
25, 100 mg in poly bottle |
Hazard Codes |
Xi |
Risk Statements |
36/37/38 |
Safety Statements |
26-36 |
RIDADR |
NONH for all modes of transport |
WGK Germany |
WGK 3 |
Flash Point(F) |
Not applicable |
Flash Point(C) |
Not applicable |